PAHC
PHIBRO ANIMAL HEALTH CORPCompany Information
- Company Name
- PHIBRO ANIMAL HEALTH CORP
- CIK
- CIK0001069899
- Category
- Large accelerated filer
- Ticker: Exchange
- PAHC: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PAHC
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-29
- Last sale
- 2026-05-07
- Shares purchased (TTM)
- 10,000
- Shares sold (TTM)
- 359,378
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 20,037,355
- Shares outstanding
- 40,546,000
- Ownership
- 49.42%
Earnings Market Reaction
- Filing date
- 2026-08-26
- Price on filing date
- —
- 1-month reaction
- -3.94%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 61 | 55 | 55 | 73 | 68 | 60 | 67 | 52 | 71 | 50 | 33 | 43 | ||||||
| Short Term Investments | 21 | 23 | 19 | 13 | 9 | 10 | 0 | 38 | 44 | 49 | 60 | 48 | ||||||
| Accounts Receivable Net Current | 239 | 222 | 216 | 218 | 228 | 198 | 192 | 161 | 169 | 161 | 151 | 149 | ||||||
| Inventory Net | 535 | 540 | 517 | 472 | 444 | 448 | 427 | 273 | 266 | 282 | 287 | 279 | ||||||
| Other Assets Current | 80 | 55 | 54 | 61 | 61 | 60 | 60 | 48 | 51 | 55 | 57 | 65 | ||||||
| Assets Current | 936 | 894 | 862 | 836 | 811 | 776 | 746 | 571 | 601 | 597 | 587 | 584 | ||||||
| Property Plant And Equipment Net | 369 | 359 | 355 | 355 | 355 | 336 | 338 | 206 | 203 | 202 | 201 | 193 | ||||||
| Finite Lived Intangible Assets Net | 30 | 32 | 33 | 35 | 36 | 38 | 40 | 43 | 45 | 48 | 51 | 52 | ||||||
| Goodwill | 60 | 60 | 60 | 60 | 60 | 55 | 55 | 55 | 55 | 55 | 55 | 53 | ||||||
| Other Assets Noncurrent | 106 | 100 | 95 | 100 | 99 | 113 | 107 | 92 | 78 | 77 | 80 | 81 | ||||||
| Assets | 1,501 | 1,445 | 1,406 | 1,386 | 1,361 | 1,317 | 1,286 | 966 | 982 | 979 | 973 | 965 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Debt Current | - | - | - | - | - | - | - | - | - | 30 | - | - | ||||||
| Loans Payable Current | 25 | 23 | 21 | 18 | 16 | 16 | 16 | 8 | 30 | - | 26 | 24 | ||||||
| Accounts Payable Current | 127 | 130 | 133 | 131 | 138 | 132 | 99 | 87 | 86 | 83 | 86 | 77 | ||||||
| Liabilities Current | 316 | 282 | 282 | 270 | 293 | 266 | 233 | 177 | 204 | 189 | 188 | 172 | ||||||
| Long Term Line Of Credit | 116 | 115 | 107 | 115 | 87 | 92 | 114 | 179 | 176 | 165 | 151 | 154 | ||||||
| Long Term Loans Payable | 592 | 598 | 604 | 610 | 615 | 619 | 623 | 288 | 282 | 291 | 298 | 305 | ||||||
| Other Liabilities Noncurrent | 92 | 89 | 80 | 79 | 79 | 74 | 69 | 64 | 63 | 64 | 65 | 60 | ||||||
| Liabilities | 1,116 | 1,083 | 1,073 | 1,074 | 1,075 | 1,051 | 1,039 | 708 | 726 | 709 | 702 | 691 | ||||||
| Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 139 | 138 | 138 | 137 | 137 | 137 | 137 | 136 | 136 | 136 | 136 | 136 | ||||||
| Retained Earnings Accumulated Deficit | 353 | 336 | 317 | 294 | 273 | 260 | 244 | 246 | 244 | 248 | 244 | 248 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -106 | -112 | -122 | -120 | -124 | -131 | -134 | -124 | -124 | -114 | -110 | -111 | ||||||
| Stockholders Equity | 385 | 362 | 332 | 312 | 286 | 266 | 247 | 259 | 257 | 270 | 271 | 273 | ||||||
| Liabilities And Stockholders Equity | 1,501 | 1,445 | 1,406 | 1,386 | 1,361 | 1,317 | 1,286 | 966 | 982 | 979 | 973 | 965 | ||||||
| Common Class A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Class B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Preferred Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPHIBRO ANIMAL HEALTH CORP (PAHC) — SEC Financial Statements & Analysis
PHIBRO ANIMAL HEALTH CORP (PAHC) is a pharmaceutical preparations company, incorporated in DE. PHIBRO ANIMAL HEALTH CORP trades on Nasdaq as: PAHC. PHIBRO ANIMAL HEALTH CORP (PAHC)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-26. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PHIBRO ANIMAL HEALTH CORP carries a market cap of $1.27B, a P/E ratio of 12.73x, a P/B ratio of 3.29x, a P/S ratio of 0.84x, an enterprise value of $1.23B, and an EV/EBITDA multiple of 5.01x. On profitability, it posts a gross margin of 33.76%, an operating margin of 12.81%, a net margin of 6.57%, a Return on Equity (ROE) of 29.72%, a Return on Assets (ROA) of 6.97%, and a Return on Invested Capital (ROIC) of 44.16%. Per share, it reports EPS of $2.46, diluted EPS of $2.43, free cash flow per share of $0.24, and a dividend per share of $0.48. Over the trailing year, it posted revenue growth of 17.12% year-over-year, net income growth of 106.61% year-over-year, and EPS growth of 106.46% year-over-year. On the balance sheet, it maintains a current ratio of 2.96x, a quick ratio of 1.27x, working capital of $619.04M, a debt-to-equity ratio of 2.89x, a debt ratio of 0.74, an interest coverage ratio of 4.38x, free cash flow of $9.87M (TTM), and net debt of $-36.39M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.27B
- P/E TTM
- 12.73x
- EPS TTM
- $2.46
- P/B TTM
- 3.29x
- ROE TTM
- 29.72%
- ROA TTM
- 6.97%
- Debt To Equity
- 2.89x
- Free Cash Flow TTM
- $9.87M
- Net Revenue TTM Growth 1Y
- 17.12%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PHIBRO ANIMAL HEALTH CORP in?
PHIBRO ANIMAL HEALTH CORP (PAHC) operates in the Pharmaceutical Preparations industry.
What exchange does PAHC trade on?
PHIBRO ANIMAL HEALTH CORP (PAHC) trades on the Nasdaq.
Where is PHIBRO ANIMAL HEALTH CORP incorporated?
PHIBRO ANIMAL HEALTH CORP is incorporated in DE.
When was PHIBRO ANIMAL HEALTH CORP (PAHC)'s most recent SEC filing?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-26.
What is PAHC's market cap?
PHIBRO ANIMAL HEALTH CORP (PAHC) has a market capitalization of $1.27B as of 2026-06-30.
What is PAHC's P/E ratio?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s trailing twelve month P/E ratio is 12.73x as of 2026-06-30.
What is PAHC's EPS (earnings per share)?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s trailing twelve month EPS is $2.46 as of 2026-06-30.
What is PAHC's ROE (return on equity)?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s trailing twelve month Return on Equity (ROE) is 29.72% as of 2026-06-30.
What is PAHC's ROA (return on assets)?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s trailing twelve month Return on Assets (ROA) is 6.97% as of 2026-06-30.
What is PAHC's ROIC (return on invested capital)?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s trailing twelve month Return on Invested Capital (ROIC) is 44.16% as of 2026-06-30.
What is PAHC's EV/EBITDA?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s trailing twelve month EV/EBITDA is 5.01x as of 2026-06-30.